Victoria Enwemadu is vice president, business development and projects, at Fyodor Biotechnologies Inc. She’s responsible for the leadership and support of various projects which facilitate the manufacturing, registration, launch and commercialization activities of Fyodor’s molecular diagnostic products for emerging and developing markets. She has more than 15 years of experience in the pharmaceutical, hospital and retail sectors including project management, literature analysis, medical communications and management of scientific publication activities. Prior to joining Fyodor, Enwemadu served as a senior publication manager at Merck in several therapeutic areas such as HIV, hepatitis C and fungal infections. She earned a doctorate in pharmacy from the University of Florida and a bachelor’s degree in pharmacy from Rutgers College of Pharmacy. Enwemadu is a member of the American Pharmacists Association and Nigerian Association of Pharmacists and Pharmaceutical Scientists. Her email is victoria.enwemadu@fyodorbio.com.
